Public trial registry of the CCC-Munich

Trial TPU-S1119

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
TPU-S1119
World
Full title
:

OFFENE, NICHT-RANDOMISIERTE PHASE I, DOSISFINDUNGS-, SICHERHEITS- UND VERTR√ĄGLICHKEITSSTUDIE VON ORAL VERABREICHTEM TEYSUNO (S-1) IN KOMBINATION MIT EPIRUBICIN UND OXYLIPLATIN BEI PATIENTEN MIT FORTGESCHRITTENEN SOLIDEN TUMOREN

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
- Comprehensive trials
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
I
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2015-08-31 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization